Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis

Alessandra D'Abramo, Maria Antonella Zingaropoli, Alessandra Oliva, Claudia D'Agostino, Samir Al Moghazi, Giulia De Luca, Marco Iannetta, Claudio Maria Mastroianni, Vincenzo Vullo

Research output: Contribution to journalArticle

Abstract

HIV-infected patients have a significantly greater risk of cardiovascular disease. Several markers including osteoprotegerin have been shown to be involved in the development and progression of atherosclerosis. We investigated the relationship between T-cell phenotype, osteoprotegerin, and atherosclerosis evaluated by carotid intima-media thickness (c-IMT) in 94 HIV+ patients on suppressive antiretroviral therapy with Framingham score

Original languageEnglish
Article number192594
JournalMediators of Inflammation
Volume2014
DOIs
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Immunology
  • Cell Biology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis'. Together they form a unique fingerprint.

Cite this